Author: GlobeNewswire

ROCKVILLE, Md., Oct. 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

TORONTO, Oct. 27, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage…

– All Stockholder Proposals Were Approved – – Transaction Expected to Close Early November – AMITYVILLE, N.Y., Oct. 27, 2021…

SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…

BOULDER, Colo., Oct. 27, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell”), a clinical-stage pharmaceutical company striving to…

JUPITER, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),…

Alan Fuhrman, experienced biotech executive and Checkmate board member, appointed as interim President and CEOCAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE…

DURHAM, N.C., Oct. 27, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…

Saint Herblain (France), October 27, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE…